Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$19,052,571
+$1,077,433 QoQ
Shares Held
75,019
+2.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
3.26%
of 13F equity value
Holder Rank
#758
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 22%
Shared 78%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Broderick Brian C holds $42,167,593 across 9 Drug Manufacturers - General names. JNJ ranks #1 (45.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
75,019 | $19,052,571 | |
| 2 | LLY |
ELI LILLY & Co
|
11,816 | $14,172,462 | |
| 3 | ABBV |
AbbVie Inc.
|
14,011 | $3,525,726 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,484 | $3,017,692 | |
| 5 | PFE |
Pfizer Inc
|
28,800 | $693,504 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
10,117 | $582,941 | |
| 7 | NVS |
Novartis AG
|
2,946 | $461,696 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,310 | $418,185 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,052,571 | 75,019 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $17,975,138 | 73,536 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $14,515,471 | 70,140 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,031,317 | 70,280 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $11,015,410 | 72,114 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $12,760,888 | 76,947 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $11,324,611 | 78,306 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $12,975,817 | 80,068 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $11,832,674 | 80,957 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $12,545,730 | 79,308 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $11,923,993 | 76,075 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,250,132 | 72,232 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $11,741,822 | 70,939 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $10,814,660 | 69,772 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $12,313,209 | 69,704 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $11,266,610 | 68,968 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $11,983,875 | 67,511 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $12,035,333 | 67,908 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $11,594,781 | 67,778 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $10,518,170 | 65,128 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $10,858,999 | 65,916 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $10,886,870 | 66,242 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $10,447,039 | 66,381 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $9,899,030 | 66,490 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $9,586,322 | 68,167 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $9,077,865 | 69,228 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||